Heading into the fifth U.S. winter of COVID-19, an Emory University lab has found the presence – or absence – of a particular ...

Scientists examine the effectiveness of an antibody targeting cell adhesion molecule 1 in alleviating pain-induced neuronal ...

Cancer treatment has entered a revolutionary phase with advancements in immunotherapy, a field that employs the immune system ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Researchers suggest broadly reactive antibodies identified are likely to represent a common mechanism of acquired immunity to ...

ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and ...

Malaria is a life-threatening disease that is transferred by mosquito bites. Interestingly, a specific type of mosquito can ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Zanidatamab is the first agent approved specifically for advanced, HER2-positive second-line biliary tract cancer.

The Humane Society of Western Montana (HSWM) is caring for six puppies, one of which tested positive for the deadly ...